Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions

Journal of Experimental Medicine

Volumn 182, Issue 6, 1995, Pages 1985-1996

  Windhagen, Anja ^a   Newcombe, Jia ^b   Dangond, Fernando ^a   Strand, Catherine ^b   Woodroofe, M Nicola ^b,c   Cuzner, M Louise ^b   Hafler, David A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; INTERLEUKIN 12;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD80; BASE SEQUENCE; BRAIN; CHILD; DNA PRIMERS; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; INTERLEUKIN-12; LYMPHOCYTES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGE; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028809507     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.182.6.1985     Document Type: Article

References (55)

1. Martin, R., M.D. Howell, D. Jaraquemada, M. Flerlage, J. Richert, S. Brostoff, E.O. Long, D.E. McFarlin, and H.F. McFarland. 1991. A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J. Exp. Med. 173:19-24.
2. Pette, M., K. Fujita, D. Wilkinson, D.M. Altmann, J. Trowsdale, G. Giegerich, A. Hinkkanen, J.T. Epplen, L. Kappos, and H. Wekerle. 1990. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA. 87: 7968-7972.
3. Zhang, J., R. Medaer, Y. Chin, E. Van Den Berg-Loonen, and J.C. Raus. 1992. Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity and cytotoxicity. Ann. Neurol. 32: 330-338.
4. Ota, K., M. Matsui, E.L. Milford, G.A. Mackin, H.L. Weiner, and D.A. Hafler. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature (Lond.). 346: 183-187.
5. Powell, M.B., D. Mitchell, J. Lederman, S. Buckmeier, S. Zamvil, M. Graham, N.H. Ruddle, and L. Steinman. 1990. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2: 539-544.
6. Kuchroo, V.J., C.A. Martin, J.M. Greer, S. Ju, R.A. Sobel, and M.E. Dorf. 1993. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151: 4371-4382.
7. Allegretta, M., J. Nicklas, S. Sriam, and R.J. Albertini. 1993. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science (Wash. DC). 247: 718-721.
8. Zhang, J., S. Markovic, B. Lacet, J. Raus, H.L. Weiner, and D.A. Hafler. 1994. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179: 973-984.
9. Jenkins, M.K., C. Chen, G. Jung, D.L. Mueller, and R.H. Schwartz. 1990. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 144: 16-22.
10. Schwartz, R.H. 1990. A cell culture model for T lymphocyte clonal anergy. Science (Wash. DC). 248: 1349-1356.
11. McArthur, J.G., and D.H. Raulet. 1993. CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4. J. Exp. Med. 178: 1645-1653.
12. Linsley, P.S., and J.A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11: 191-212.
13. Green, J.M., P.J. Noel, A.I. Sperling, T.L. Walunas, G.S. Gray, J.A. Bluestone, and C.B. Thompson. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity. 1: 501-508.
14. Brunet, J.-F., F. Denizot, M.-F. Luciani, M. Roux-Dosseto, M. Suzan, M.-G. Mattei, and P. Golstein. A new member of the immunoglobulin superfamily-CTLA-4. Nature (Lond.). 328: 267-270.
15. Jenkins, M.K. 1994. The ups and downs of T cell costimulation. Immunity. 1: 443-446.
16. Wu, Y., Y. Guo, and Y. Liu. 1993. A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7.J. Exp. Med. 178: 1789-1793.
17. Linsley, P.S., W. Brady, L. Grosmaire, A. Aruffo, N.K. Damle, and J.A. Ledbetter. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin-2 mRNA accumulation. J. Exp. Med. 173: 721-730.
18. Freeman, G.J., J.G. Gribben, V.A. Boussiotis, J.W. Ng, V.A. Restivo, Jr., L.A. Lombard, G.S. Gray, and L.M. Nadler. 1993. Cloning of B7-2: CTLA-4 counter-receptor that costimulates human T cell proliferation. Science (Wash. DC). 262: 909-911.
19. Freeman, G., F. Borriello, R.J. Hodes, H. Reiser, K.S. Hathcock, G. Laszlo, A.J. McKnight, J.J. Kim, L. Du, D.B. Lombard, et al. 1993. Uncovering the functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science (Wash. DC). 262: 907-909.
20. Tan, P., C. Anasetti, J.A. Hansen, J. Melrose, M. Brunvand, J. Bradshaw, J.A. Ledbetter, and P.S. Linsley. 1993. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligland B7/BB1. J. Exp. Med. 177: 165-173.
21. Gimmi, C.D., G.J. Freeman, J.G. Gribben, G. Gray, and L.M. Nadler. 1993. Human T-cell Clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc. Natl. Acad. Sci. USA. 90: 6586-6590.
22. Turka, L.A., P.S. Linsley, H. Lin, W. Brady, J.M. Leiden, R.Q. Wei, M.L. Gibson, X.G. Zheng, S. Myrdal, and D. Gordon. 1992. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA. 89: 11102-11105.
23. Lenschow, D.J., Y. Zeng, J.R. Thistlethwaite, A. Montag, W. Brady, M.G. Gibson, P.S. Linsley, and J.A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA-4 Ig. Science (Wash. DC). 257: 789-792.
24. Linsley, P.S., P.M. Wallace, J. Johnson, M.G. Gibson, J.L. Greene, J.A. Ledbetter, C. Singh, and M.A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science (Wash. DC). 257: 792-795.
25. Harlan, D.M., H. Hengartner, M.L. Huang, Y. Kang, R. Abe, R.W. Moreadith, H. Pircher, G.S. Gray, P.S. Ohashi, G.J. Freeman, et al. 1994. Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. Proc. Natl. Acad. Sci. USA. 91: 3137-3141.
26. Guerder, S., J. Meyerhoff, and R. Flavell. 1994. The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity. 1: 155-166.
27. Wucherpfennig, K.W., H.L. Weiner, and D.A. Hafler. 1991. T-cell recognition of myelin basic protein. Immunol. Today. 12: 277-282.
28. Raine, C.S., U. Traugott, and S.H. Stone. 1978. Suppression of chronic allergic encephalomyelitis: relevance to multiple sclerosis. Science (Wash. DC). 201: 445-448.
29. Khoury, S.J., W.W. Hancock, and H.L. Weiner. 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor B, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176: 1355-1364.
30. Kennedy, M.K., D.S. Torrance, K.S. Picha, and K.M. Mohler. 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 expression correlates with recovery. J. Immunol. 149: 2496-2505.
31. Seder, R.A., and W.E. Paul. 1994. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12: 635-673.
32. Mossmann, T.R., H. Cherwinski, M.W. Bond, M.A. Giedlin, and R.L. Cofifnan. 1986. Two types of murine helper T cell clones. J. Immunol. 136: 2348-2357.
33. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev.Immunol. 12: 227-257.
34. Scott, P. 1993. IL-12: initiation cytokine for cell-mediated immunity. Science (Wash. DC). 260: 496-497.
35. Wolf, S.F., P.A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, R.M. Hewick, et al. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146: 3074-3081.
36. D’Andrea, A., M. Rengaraju, N.M. Valiante, J. Chehimi, M. Kubin, M. Aste, S.H. Chan, M. Kobayashi, D. Young, E. Nickbarg, et al. 1992. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176: 1387-1398.
37. Chan, S.H., B. Perussia, J.W. Gupta, M. Kobayashi, M. Pospisil, H.A. Young, S.F. Wolf, D. Young, S.C. Clark, and G. Trinchieri. 1991. Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173: 869-879.
38. Germann, T., M.K. Gately, D.S. Schoenhaut, M. Lohoff F. Mattner, S. Fischer, S. Jin, E. Schmitt, and E. Rude. 1993. Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Thl) but not on Th2 cells. Eur.J. Immunol. 23: 1762-1770.
39. Hsieh, C., S.E. Macatonia, C.S. Tripp, S.F. Wolf, A. O’Garra, and K. Murphy. 1993. Development of TH1 CD4+ T cells through IL-12 produced by listeria-induced macrophages. Science (Wash. DC). 260: 547-549.
40. Kuchroo, V.K., M.P. Das, J.A. Brown, A.M. Ranger, S.S. Zamvil, R.A. Sobel, H.L. Weiner, N. Nabovi, and L.H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Thl/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 80: 707-718.
41. Brosnan, C.F., K. Selmaj, and C.S. Raine. 1988. Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J. Neuroimmunol. 18: 87-94.
42. Hofinan, F.M., D.R. Hinton, K. Johnson, and J.E. Merrill. 1989. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170: 607-612.
43. Sharief, M.K., and R. Hentges. 1991. Association between tumor necrosis factor alpha and disease progession in patients with multiple sclerosis. N. Engl.J. Med. 325: 467-472.
44. Sharief, M.K., B. McLean, and E.J. Thompson. 1993. Elevated serum levels of tumor necrosis factor alpha in GuillainBarre syndrome. Ann. Neurol. 33: 591-596.
45. Panitch, H.S., R.L. Hirsch, A.A. Haley, and K.P. Johnson. 1987. Exacerbations of multiple sclerosis in patients treated with y-IEN. Lancet. 1: 893-895.
46. Woodroofe, M.N., and M.L. Cuzner. 1993. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. Cytokine. 5: 583-588.
47. Selmaj, K., C.S. Raine, B. Cannella, and C.F. Brosnan. 1991. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87: 949-954.
48. Li, H., J. Newcombe, N.P. Groome, and M.L. Cuzner. 1993. Characterization and distribution of phagocytic macrophages in MS plaques. Neuropathol. Appl. Neurobiol. 19:214-223.
49. Wucherpfennig, K.W., J. Newcombe, H. Li, C. Keddy, M.L. Cuzner, and D. Hafler. 1992. T cell receptor V alphaV beta repertoire and cytokine gene expression in active multiple sclerosis lesions. J. Exp. Med. 175: 993-1002.
50. Siebert, P.D., and J.W. Larrick. 1992. Competitive PCR. Nature (Lond.). 359: 557-558.
51. Willliams, K., E. Ulvestad, and J.P. Antel. 1994. B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur.J. Immunol. 24: 3031-3037.
52. De Simone, R., A. Giampaolo, B. Giometto, P. Gallo, G. Levi, C. Peschle, and F. Aloisi. 1995. The costimulatory molecule 137 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J. Neuropathol. Exp. Neurol. 54: 175-187.
53. Nickoloff, B.J., R.S. Mitra, K. Lee, L.A. Turka, J. Green, C. Thompson, and Y. Shimizu. 1993. Discordant expression of CD 28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo. Am. J. Pathol. 142: 1029-1040.
54. Hofinan, F.M., R.L Von Hanwehr, C.A. Dinarello, S.B. Mizel, D. Hinton, and J.E. Merrill. 1986. Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain. J. Immunol. 136: 3239-3245.
55. Cuzner, M.L., G.M. Hayes, J. Newcombe, and M.N. Woodroofe. 1988. The nature of inflammatory components during demyelination in multiple sclerosis. J. Neuroimmunol. 20: 203-209.